| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 3.18▲ | 3.19▲ | 3.18▲ | 3.25▼ | 3.43▼ |
| MA10 | 3.19▲ | 3.19▲ | 3.19▲ | 3.23▼ | 3.23▼ |
| MA20 | 3.19▲ | 3.17▲ | 3.20▲ | 3.41▼ | 3.10▲ |
| MA50 | 3.18▲ | 3.24▼ | 3.24▼ | 3.23▼ | 3.35▼ |
| MA100 | 3.25▼ | 3.35▼ | 3.41▼ | 3.13▲ | 3.83▼ |
| MA200 | 3.35▼ | 3.37▼ | 3.28▼ | 3.30▼ | 4.84▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.001▼ | 0.008▲ | 0.007▲ | -0.043▼ | 0.056▲ |
| RSI | 51.677▲ | 49.403▼ | 48.528▼ | 45.110▼ | 48.605▼ |
| STOCH | 75.000 | 55.187 | 67.193 | 33.806 | 66.524 |
| WILL %R | -10.526▲ | -22.727▲ | -14.286▲ | -68.675 | -50.833 |
| CCI | -33.451 | -43.875 | 24.974 | -79.949 | 21.196 |
| CDL | $SOPH Doji Candlestick Pattern Detected | Set Alert |
|
Wednesday, August 06, 2025 08:09 AM
Despite challenges in the biopharma sector, Sophia Genetics SA (SOPH) showcases robust growth and strategic advancements in AI and data analytics.
|
|
Tuesday, August 05, 2025 08:20 PM
Potential lumpiness in revenue due to milestone-based contracts was acknowledged by management.
|
|
Tuesday, August 05, 2025 04:34 AM
SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a global leader in data-driven medicine, today announced an expansion of its partnership with AstraZeneca ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 08/08/25 | 3.20 | 3.23 | 3.1101 | 3.18 | 24,343 |
| 07/08/25 | 3.14 | 3.2772 | 3.03 | 3.20 | 49,294 |
| 06/08/25 | 3.15 | 3.35 | 3.14 | 3.1482 | 48,513 |
| 05/08/25 | 2.99 | 3.48 | 2.92 | 3.42 | 1,043,041 |
| 04/08/25 | 3.25 | 3.56 | 3.22 | 3.30 | 104,958 |
| 01/08/25 | 3.10 | 3.2203 | 3.10 | 3.16 | 24,042 |
| 31/07/25 | 3.18 | 3.33 | 3.12 | 3.13 | 20,488 |
| 30/07/25 | 3.24 | 3.4285 | 3.18 | 3.18 | 8,229 |
| 29/07/25 | 3.42 | 3.4899 | 3.2301 | 3.27 | 33,075 |
| 28/07/25 | 3.58 | 3.7321 | 3.30 | 3.36 | 21,766 |
|
|
||||
|
|
||||
|
|